Literature DB >> 11897521

Coronary risk stratification in patients with end-stage lung disease.

Aditya K Kaza1, Jeffrey F Dietz, John A Kern, David R Jones, Mark K Robbins, Steven M Fiser, Stewart M Long, James D Bergin, Irving L Kron, Curtis G Tribble.   

Abstract

BACKGROUND: Significant coronary artery disease (CAD) has been a contraindication for listing patients for lung transplantation. We hypothesize that coronary risk stratification can help identify a sub-set of patients who need additional diagnostic tools and intervention.
METHODS: We performed a retrospective review of 72 consecutive patients who underwent lung transplantation at our institution from 1995 to 2000. Further, a review of patients who are currently listed for transplantation yielded 48 patients. We then identified the various risk factors for CAD, the diagnostic tools used, and pre-operative intervention. Risk factors identified included smoking history, diabetes, hypertension, hypercholesterolemia, CAD, congestive heart failure, age >50, and arrhythmias. Based on these risk factors, the patients were then classified into 2 groups: low risk (< or =1 risk factors) and high risk (> or =2 risk factors). We identified the patients in each group who underwent coronary angiography (CA), those with angiographic evidence of CAD, and those who received pre-operative intervention.
RESULTS: Of the 72 patients who underwent lung transplantation, 48 were identified as at high risk for CAD. Of these, 5 patients had CAD diagnosed before surgery using CA, and 1 patient received pre-operative intervention. Of the 48 patients currently on the lung transplant list, we identified 28 patients as high risk for CAD, 12 of whom were noted to have CA, and 2 of whom received pre-operative intervention.
CONCLUSIONS: Although CAD was once a contraindication for lung transplantation, pre-operative risk stratification allows identification of CAD with CA in a high-risk group. We believe that by using appropriate pre-operative cardiac intervention, patients with severe CAD could successfully undergo lung transplantation.

Entities:  

Mesh:

Year:  2002        PMID: 11897521     DOI: 10.1016/s1053-2498(01)00387-4

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  2 in total

Review 1.  Prevalence of obstructive coronary artery disease in patients undergoing lung transplantation: case series and review of the literature.

Authors:  Robert M Jones; Kyle B Enfield; Borna Mehrad; Ellen C Keeley
Journal:  Catheter Cardiovasc Interv       Date:  2013-11-19       Impact factor: 2.692

2.  Preoperative mild-to-moderate coronary artery disease does not affect long-term outcomes of lung transplantation.

Authors:  Giorgio Zanotti; Matthew G Hartwig; Anthony W Castleberry; Jeremiah T Martin; Linda K Shaw; Judson B Williams; Shu S Lin; Robert D Davis
Journal:  Transplantation       Date:  2014-05-27       Impact factor: 4.939

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.